Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37+0.04 (+3.01%)
Close on Nov 17, 2026Market cap $5.00MP/E –Yield –
Pulmatrix total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Pulmatrix's total debt was $0 at Dec 31, 2018. For fiscal 2018 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $3.22M | -44.5% |
| FY2016 | Dec 31, 2016 | $5.80M | -13.7% |
| FY2015 | Dec 31, 2015 | $6.72M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $2.52M | -51.3% |
| Q4 FY2017 | Dec 31, 2017 | $3.22M | -44.5% |
| Q3 FY2017 | Sep 30, 2017 | $3.90M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.80M | – |
See a number that looks wrong?